SynAct Pharma AB Gains Spotlight Amid U.S. State’s Digital Currency Initiative
SynAct Pharma AB, a Swedish biotechnology company, is making headlines with its innovative approach to digital finance, potentially reshaping the industry and its impact on the broader biotechnology sector.
One minute to read